Literature DB >> 2489038

Structural analysis of a peptide--HLA class II complex: identification of critical interactions for its formation and recognition by T cell receptor.

J B Rothbard1, R Busch, K Howland, V Bal, C Fenton, W R Taylor, J R Lamb.   

Abstract

An assay for the binding of peptides to major histocompatibility complex (MHC) class II proteins on the surface of cells has been used to determine the relative importance of the amino acids composing an influenza haemagglutinin T cell determinant in binding. The important contact residues were identified by the effect substitution of each residue with biotinylated lysine had on the ability of the peptide to bind. The spacing of the critical residues within the peptide sequence was consistent with the central core, of approximately eight amino acids, adopting a helical conformation. The terminal residues were less constrained and might not be part of a regular conformation. Increasing the helical propensity of the determinant, by simply acetylating and amidating the peptide, resulted in an analogue that was able to stimulate a specific T cell clone at significantly lower concentrations than the natural sequence. A potential location for the peptide in the binding site was postulated based on the presence of complementary amino acids in the class II molecule and supported by screening a large number of peptide analogues for their ability either to bind the restriction element or to stimulate T cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2489038     DOI: 10.1093/intimm/1.5.479

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  15 in total

Review 1.  MHC class II epitope predictive algorithms.

Authors:  Morten Nielsen; Ole Lund; Søren Buus; Claus Lundegaard
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

2.  Flexibility in T-cell receptor ligand repertoires depends on MHC and T-cell receptor clonotype.

Authors:  A Geluk; K E van Meijgaarden; T H Ottenhoff
Journal:  Immunology       Date:  1997-03       Impact factor: 7.397

3.  Elevation of c-MYC disrupts HLA class II-mediated immune recognition of human B cell tumors.

Authors:  Jason M God; Christine Cameron; Janette Figueroa; Shereen Amria; Azim Hossain; Bettina Kempkes; Georg W Bornkamm; Robert K Stuart; Janice S Blum; Azizul Haque
Journal:  J Immunol       Date:  2015-01-16       Impact factor: 5.422

4.  Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding.

Authors:  T S Jardetzky; J C Gorga; R Busch; J Rothbard; J L Strominger; D C Wiley
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

5.  Stress-induced modulation of antigen-presenting cell function.

Authors:  A D Rees; Y Donati; G Lombardi; J Lamb; B Polla; R Lechler
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

6.  Lymphocyte responses to DR1/4 restricted peptides in rheumatoid arthritis.

Authors:  M A Skinner; L Watson; A Geursen; P L Tan
Journal:  Ann Rheum Dis       Date:  1994-03       Impact factor: 19.103

7.  Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells--specificity and promiscuity.

Authors:  M Fridkis-Hareli; D Teitelbaum; E Gurevich; I Pecht; C Brautbar; O J Kwon; T Brenner; R Arnon; M Sela
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

8.  Delineation of antigen contact residues on an MHC class II molecule.

Authors:  J Peccoud; P Dellabona; P Allen; C Benoist; D Mathis
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

9.  Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy.

Authors:  F Ferreira; K Hirtenlehner; A Jilek; J Godnik-Cvar; H Breiteneder; R Grimm; K Hoffmann-Sommergruber; O Scheiner; D Kraft; M Breitenbach; H J Rheinberger; C Ebner
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

10.  Presentation of antigen by mixed isotype class II molecules in normal H-2d mice.

Authors:  G Ruberti; K S Sellins; C M Hill; R N Germain; C G Fathman; A Livingstone
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.